Article
Intravenous diazepam application in a departmental convulsive status epilepticus protocol with CYP2C19 polymorphisms: a pediatric prospective cohort study.
BMC pharmacology & toxicology - 5 Jun 2026
Seker Gezici Muazzez, Turan Caner, Ayyildiz Emecen Durdugul, Kanmaz Seda, Isik Esra, Yurtseven Ali, Atik Tahir, Yilmaz Sanem Keskin, Tekgul Hasan, Saz Eylem Ulas
Abstract excerpt
BACKGROUND: Individual variability of therapeutic response and adverse effects of diazepam is frequently observed in pediatric cohorts. It might be related to the genetic polymorphisms in cytochrome P450 2C19 (CYP2C19), a principal enzyme mediating diazepam metabolism. OBJECTIVES: To investigate the association between CYP2C19*2 (c.681G > A), CYP2C19*3 (c.636G > A), and CYP2C19*17 (-806 C > T) polymorphisms and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
